Alpy, Fabien
104  results:
Search for persons X
?
1

STARD3: A New Biomarker in HER2-Positive Breast Cancer:

Lodi, Massimo ; Voilquin, Laetitia ; Alpy, Fabien...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15020362.  , 2023
 
?
2

STARD3: A New Biomarker in HER2-Positive Breast Cancer:

Lodi, Massimo ; Voilquin, Laetitia ; Alpy, Fabien...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15020362.  , 2023
 
?
 
?
 
?
 
?
 
?
 
?
10

CLDN1 sensitizes triple-negative breast cancer cells to che..:

Lemesle, Marine ; Geoffroy, Marine ; Alpy, Fabien...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14205026.  , 2022
 
?
 
?
12

In situ artificial contact sites (ISACS) between synthetic ..:

Milanini, Julie ; Magdeleine, Maud ; Fuggetta, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jbc.2022.101780.  , 2022
 
?
13

In situ artificial contact sites (ISACS) between synthetic ..:

Milanini, Julie ; Magdeleine, Maud ; Fuggetta, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jbc.2022.101780.  , 2022
 
?
14

In situ artificial contact sites (ISACS) between synthetic ..:

Milanini, Julie ; Magdeleine, Maud ; Fuggetta, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jbc.2022.101780.  , 2022
 
?
15

CLDN1 sensitizes triple-negative breast cancer cells to che..:

Lemesle, Marine ; Geoffroy, Marine ; Alpy, Fabien...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14205026.  , 2022
 
1-15